# Treatment of Functional Bowel Disorders

> **NCT00006157** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 300 (—)

## Conditions studied

- Irritable Bowel Syndrome
- Constipation
- Abdominal Pain
- Functional Colonic Diseases

## Interventions

- **DRUG:** Desipramine
- **BEHAVIORAL:** Cognitive Behavioral Treatment

## Key facts

- **NCT ID:** NCT00006157
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** —
- **Final completion:** 2001-03
- **Target enrollment:** 300 (—)
- **Last updated:** 2010-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006157, "Treatment of Functional Bowel Disorders". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00006157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*